Dr. Anand Patel, MD, explains how
myelofibrosis (
MF) is
managed and
treated across different stages of the disease. He discusses
early MF, sometimes called
prefibrotic or
cellular-phase disease, where blood counts may be high and treatment may focus on
symptom relief or careful
monitoring. Dr. Patel provides an overview of current standard treatments, including
JAK inhibitors, which can reduce spleen size and improve symptoms but are not curative. He explains that
stem cell transplant is currently the only potential cure, though it is reserved for selected patients based on disease risk, overall health, and donor availability. Dr. Patel also describes
treatment goals,
lifestyle considerations during
watchful waiting, and the importance of ongoing
communication between patients and their care teams when making treatment decisions.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about myeloproliferative neoplasms which will help other patients, caregivers, and families.